BT
NVO

Beacon Trust’s Novo Nordisk NVO Stock Holding History

Beacon Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,900
Closed -$268K – 189
2016
Q1 		$268K Hold
9,900
– – 0.05% 152
2015
Q4 		$287K Hold
9,900
– – 0.05% 149
2015
Q3 		$268K Hold
9,900
– – 0.05% 159
2015
Q2 		$271K Sell
9,900
-4,000
-29% -$112K 0.04% 169
2015
Q1 		$371K Sell
13,900
-5,550
-29% -$128K 0.06% 156
2014
Q4 		$411K Buy
+19,450
New +$434K 0.06% 149
2013
Q4 		– Sell
-20,100
Closed -$340K – 196
2013
Q3 		$340K Sell
20,100
-210
-1% -$3.53K 0.06% 138
2013
Q2 		$315K Buy
+20,310
New +$338K 0.06% 141

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Beacon Trust's NVO Position: Q2 2016 in Review

Beacon Trust sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 9,900 shares — an estimated $268K sold.

Beacon Trust first reported a position in NVO in Q2 2013 and held it in 8 quarters. The position peaked at $411K in Q4 2014. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • Beacon Trust reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • Beacon Trust sold 9,900 Novo Nordisk shares in Q2 2016, an estimated $268K.
  • Beacon Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 8 quarters.
  • Beacon Trust's Novo Nordisk position peaked at $411K in Q4 2014.
  • 530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on Beacon Trust's 13F filing for Q2 2016, filed 3 Aug 2016.